Broadfin Capital, LLC - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$2,735,000
-84.4%
441,088
-82.1%
0.60%
-83.6%
Q1 2019$17,561,000
-21.3%
2,469,894
-5.5%
3.63%
+23.5%
Q4 2018$22,328,000
-16.0%
2,614,468
+96.8%
2.94%
-25.0%
Q3 2018$26,595,000
-27.3%
1,328,424
-6.3%
3.91%
-32.1%
Q2 2018$36,604,000
+34.9%
1,417,121
+24.8%
5.76%
+36.3%
Q1 2018$27,131,0001,135,2034.23%
Other shareholders

There were no reported owners of ADAMAS PHARMACEUTICALS INC in Q2 2018.

NameSharesValueWeighting ↓
View complete list of ADAMAS PHARMACEUTICALS INC shareholders